Stock Analiz

Jin Medical International Ltd. ZJYL

Industrial Specialties · IPO 2023 · data as of November 13, 2026

$3.50Market cap $554M
Open the interactive analysis →

Jin Medical International Ltd. (ZJYL) is a healthcare company listed in the US with a market value of about $554M. In the twelve months to March 31, 2026 it had revenue of $20M and net income of $1M, a net margin of 5.9%.

Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is financial health (3/5); the weakest is shareholder returns (0/5).

Key numbers: a P/E of 18.4, a 5-year average ROIC of 10%.

About Jin Medical International

Jin Medical International is listed in the US and classified in industrial specialties, IPO year 2023. Revenue went from $21M in 2021 to $21M in 2025, a decline of about 0.1% a year. It was profitable in 5 of the last 5 years in our data. It spends 8% of revenue on research and development.

Score: 1.4 / 5

Value2/5
Future growth1/5
Track record1/5
Financial health3/5
Shareholder returns0/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • Strong R&D investment or growth above 20%
  • Profitable 5 years in a row
  • More cash than debt, or low debt to equity
  • Interest covered more than 5 times
  • Liabilities below 60% of assets

Checks not passed

  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)18.4
Forward P/E—
P/FCF—
P/S28.1
P/B18.3
EV/EBITDA828.3
PEG—
Dividend yield0.00%
FCF yield-1.3%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)-12.0%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)12.5%
ROIC (5-yr avg.)9.7%
Profitable years (of last 10)5
Years paying a dividend—

Financials, last 5 years

Fiscal yearTTM20252024202320222021
Revenue$20M$21M$24M$20M$19M$21M
Net income$1M$1M$4M$3M$3M$3M
Free cash flow-$7M-$4M-$1M$3M$2M$6M
EPS (diluted)$0.01$0.01$0.02$0.02$0.02$0.02
Net margin5.9%5.8%15.6%14.5%14.1%12.7%
ROIC—1.1%7.4%9.1%13.8%17.1%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

What is Jin Medical International’s P/E ratio?

About 18.4, based on the last twelve months of diluted earnings per share.

Does Jin Medical International pay a dividend?

Not currently.

Is Jin Medical International a good stock to buy?

We do not give buy or sell advice. Jin Medical International scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.